$18.44
-2.16-10.49%
At close: -
$18.11
-0.33-1.79%
After Hours: 4:06 PM EDT
Comments
Loading...
Immunovant Earnings Estimates, EPS & Revenue | NASDAQ:IMVT | Benzinga
Immunovant reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 28
EPS Estimate
$-0.770
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Immunovant using advanced sorting and filters.
Data brought to you by Benzinga APIs
Immunovant (IMVT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-06 | $-0.76 | $-0.76 | 0.00 % |
| Q2 | 2024-11-07 | $-0.74 | $-0.60 | -23.3 % |
| Q1 | 2024-08-06 | $-0.60 | $-0.53 | -13.2 % |
| Q4 | 2024-05-29 | $-0.52 | $-0.43 | -20.9 % |
Immunovant (IMVT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Immunovant (NASDAQ:IMVT) reporting earnings?
Immunovant (IMVT) is scheduled to report earnings on May 28, 2025. The last reported earnings were for reported on February 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Immunovant (NASDAQ:IMVT)?
The Actual EPS was $-0.76, which hit the estimate of $-0.76.
What were Immunovant’s (NASDAQ:IMVT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.